HearingAssist Eaze vs Resound Vivia 9 60S microRIE

The HearingAssist Eaze is a budget-priced OTC hearing aid that earned a B grade with a SoundScore of 3.4/5 in our lab testing. At $399, it positions itself as an affordable behind-the-ear option in the crowded OTC market, ranking #43 of 65 OTC hearing aids tested. In our testing, the Eaze showed mixed results across performance categories. Its standout strength is excellent feedback handling, scoring a perfect 5.0/5—0.46 points above the category average. This means users can expect stable performance without whistling during typical daily activities. However, speech performance is a weakness: speech in quiet scored 2.6/5 (0.20 points below average) and speech in noise scored just 1.3/5 (also 0.20 points below average), which may limit benefit in challenging listening environments. The most significant limitation is music streaming, which scored 0.0/5—nearly 2 points below the category average of 1.92/5. Consumers who prioritize streaming audio from their phones should consider alternatives. Own-voice comfort also scored below average at 2.2/5, which may affect how natural users sound to themselves. At this price point, buyers have several higher-scoring alternatives to consider, including the Elehear Beyond (4.34/5) and Apple AirPods Pro 2 (4.04/5). The Eaze may suit budget-conscious consumers who prioritize feedback-free wear over streaming capability and don't frequently encounter noisy environments.

The ReSound Vivia 9 60S microRIE is a premium prescription behind-the-ear hearing aid released in 2025, currently available at $3,798. In our lab testing, it earned a B grade with a SoundScore of 3.9/5, ranking #29 of 39 prescription hearing aids tested. This device shows a mixed performance profile. Its standout strength is own-voice comfort, scoring 3.4/5—a solid result that sits 0.70 points above the category average. Speech clarity in quiet environments also performs at category average with a score of 3.4/5. Feedback handling is strong in absolute terms at 4.2/5, though this falls 0.52 points below the category average, reflecting the high bar set by competing prescription devices. The Vivia 9's most notable weakness is speech understanding in noisy environments, where it scored just 1.1/5—a low result that trails the category average by 0.96 points. Music streaming performance is mixed at 2.6/5, sitting slightly below average. These limitations are worth considering given the premium price positioning. For listeners who prioritize comfortable own-voice perception and primarily encounter quieter listening situations, the Vivia 9 may be suitable. However, those frequently in challenging noise environments should note that several alternatives in this price range—including the Phonak Sphere Infinio and Oticon Intent—deliver stronger overall performance in our testing. Budget-conscious shoppers may also find comparable sound quality at lower price points with options like the Jabra Enhance Pro 20 at Costco.